NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Managed Care Weekly Digest

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiotensins



Diabetic Beneficiaries Receive Extra Push to Stay Healthy



June 18th, 2007

For many people with diabetes, kidney damage and cardiovascular complications are devastating side effects of the disease. Fortunately, two classes of medications - ACEI (Angiotensin Converting Enzyme Inhibitors) or ARB (Angiotensin Receptor Blockers) - have been proven to help reduce the progression of kidney and cardiovascular problems.

To help keep its diabetic beneficiaries healthy, MemberHealth's CCRx Medicare Part D Prescription Drug Plan recently started working with physicians to ensure they prescribe ACEIs or ARBs for beneficiaries with diabetes. As a result, 68 percent of CCRx's beneficiaries with diabetes are now taking an ACEI or ARB.

...


Source: Managed Care Weekly Digest (2007-06-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login